MedTrace Logo

Neuromuscular Training in Recreational Tennis Players

NCT06665750 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-10-30

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of upper extremity neuromuscular exercise training on throwing performance, upper extremity strength, and endurance in recreational tennis players. In this context, 24 recreational tennis players will be included in the study. Participants will be divided into two equal groups using a simple randomization method. The study group (n=12) will receive progressive upper extremity neuromuscular exercise training twice a week for six weeks before each tennis training session, while the control group will perform only routine warm-up exercises. Both groups will be evaluated twice, once at the beginning of the study and again at the end of the six-week intervention. Throwing performance will be assessed using the Functional Throwing Performance Index (FTPI) and the International Tennis Number Test (ITN). Upper extremity endurance will be evaluated through the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and Scapula Muscle Endurance Test (SME), while upper extremity strength will be measured using the Health Ball Throw Test (HBT) and the Y Balance Upper Extremity Test (YBUET). Statistical analysis will be conducted using SPSS 24.0 software.

Conditions

  • Sport Injuries

Interventions

BEHAVIORAL

Exercise

A progressive upper extremity neuromuscular exercise program was performed face to face with the researcher physiotherapist for the study group. The exercise program was applied for approximately 20 minutes, 2 days a week for 6 weeks, on the same days of the week, before the participants' tennis training. The exercise content and number of repetitions in the training program changed every 2 weeks with increasing difficulty.

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06665750 on ClinicalTrials.gov